The CIHR New Emerging Team for Rare Diseases is offering 2 year, non-renewable Postdoctoral Fellowship starting in 2013.
As our understanding of diseases and how to treat them evolves, so too must our decision making procedures for providing treatments for those living with an illness. Today, one area of policy and decision making that lags behind is that for treatment of rare diseases. To address these issues, we have assembled a team of experts from across Canada. As a team, our primary aim is to undertake collaborative translational research to help inform the development of drug coverage decision-making models relating to government funding of drug therapy for rare diseases. The research findings generated by our team will advance the understanding of policy issues of pressing importance to health planners and decision makers regarding technology assessment, incentives for innovation, drug pricing, and priority setting.
Applicants will have a PhD in epidemiology, health economics, health policy, health ethics/bioethics, human genetics, law, or a discipline related to the objectives of the team’s research priorities, with experience and interests in the area of orphan drugs and rare diseases. The successful applicant will be responsible for research in any discipline related to funding and reimbursement of expensive drugs for rare diseases.
Under the auspices of the New Emerging Team in Rare Diseases (www.rare-diseases.ca), the Fellow will have a unique opportunity to be supervised and mentored by leading researchers, clinicians, and policy makers from across Canada. The applicant will be required to provide a rationale and justification for their choice of primary supervisor/mentor, and to outline their specific objectives for the duration of the fellowship. Once a primary supervisor/mentor and institution is selected, a diversified training program will be developed such that the Fellow will be provided with opportunities for external ‘rotations’ with other team members at other institutions. The primary supervisor/mentor must be one of the research team members listed below:
University of British Columbia, Vancouver Campus:
Dr. Larry Lynd (Faculty of Pharmaceutical Sciences)
Dr. Carlo Marra (Faculty of Pharmaceutical Sciences)
Dr. Stirling Bryan (Faculty of Medicine, School of Population and Public Health)
Dr. Craig Mitton (Faculty of Medicine, School of Population and Public Health)
Dr. Peter Klein (School of Journalism)
McGill University, Centre for Genomics and Policy:
Dr. Bartha Maria Knoppers (Faculty of Medicine, Department of Human Genetics)
Dr. Vural Ozdemir (Faculty of Medicine, Department of Human Genetics)
Dr. Yann Joly (Faculty of Medicine, Department of Human Genetics)
University of Ottawa:
Dr. Doug Coyle (Faculty of Medicine, Department of Epidemiology and Community Medicine)
University of Toronto:
Dr. Fiona Miller (Institute of Health Policy, Management, and Evaluation)
The closing date for all applications is November 30, 2012.
Preferred start date is negotiable. Please send curriculum vitae, a description of your research experience and most significant research accomplishments, a statement of your research interests, and the contact information for three referees to:
Ms. Litsa Blanis
Project Manager, CIHR New Emerging Team for Rare Diseases
Faculty of Pharmaceutical Sciences
The University of British Columbia
371E - 2146 East Mall
Vancouver, BC Canada V6T 1Z3
UBC hires on the basis of merit and is committed to employment equity. All qualified persons are encouraged to apply. We especially welcome applications from members of visible minority groups, women, Aboriginal persons, persons with disabilities, persons of minority sexual orientations and gender identities, and others with the skills and knowledge to engage productively with diverse communities. Canadians and permanent residents of Canada will be given priority.